BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 197 filers reported holding BLUEBIRD BIO INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $128 | -0.8% | 41,942 | +6.7% | 0.00% | 0.0% |
| Q2 2023 | $129 | -0.8% | 39,319 | -4.1% | 0.00% | 0.0% |
| Q1 2023 | $130 | -73.4% | 40,985 | -42.0% | 0.00% | -71.4% |
| Q4 2022 | $489 | -99.8% | 70,609 | +73.9% | 0.01% | +40.0% |
| Q3 2022 | $257,000 | +50.3% | 40,604 | -1.8% | 0.01% | +66.7% |
| Q2 2022 | $171,000 | +3.0% | 41,348 | +20.6% | 0.00% | +50.0% |
| Q1 2022 | $166,000 | -35.9% | 34,291 | +32.4% | 0.00% | -60.0% |
| Q4 2021 | $259,000 | -63.1% | 25,891 | -29.6% | 0.01% | -61.5% |
| Q3 2021 | $702,000 | -69.5% | 36,756 | -49.0% | 0.01% | -71.7% |
| Q2 2021 | $2,303,000 | – | 72,003 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 125,000 | $13,131,000 | 5.55% |
| Cormorant Asset Management, LP | 275,000 | $28,889,000 | 4.79% |
| Eventide Asset Management | 569,700 | $59,847,000 | 3.73% |
| Crosspoint Capital Strategies, LLC | 28,937 | $3,040,000 | 2.66% |
| Casdin Capital, LLC | 65,000 | $6,828,000 | 2.53% |
| ARK Investment Management | 119,683 | $12,573,000 | 2.45% |
| RTW INVESTMENTS, LP | 104,383 | $10,965,000 | 2.31% |
| Taylor Wealth Management Partners | 38,368 | $4,031,000 | 1.82% |
| First Light Asset Management, LLC | 33,780 | $3,549,000 | 1.19% |
| Atika Capital Management LLC | 25,000 | $2,627,000 | 0.92% |